WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to share ACRO’s Diversity, Equity, and Inclusion Principles Statement.
Created collaboratively by members of the committee and ratified by the Board, the Principles Statement is comprised of four key principles and associated actions that are vital to the work of ensuring all trials are diverse, inclusive, and equitable.
The Principles Statement is available to download on ACRO’s website.
ACRO’s Diversity and Inclusion Principles include:
● Improving Health Equity Through Access to Trials
● Empowering Research Partners
● Partnering with Stakeholders & Policy Makers
● Driving Workforce Diversity, Equity, & Inclusion
“ACRO’s Diversity and Inclusion in Clinical Trials committee created these Principles to demonstrate our shared commitment to advancing diversity, equity and inclusion in clinical trials and bring focus to the key actions ACRO and its member companies are taking toward advancing a more inclusive clinical research ecosystem,” said Committee Chair Rachael Fones, Director, Government and Public Affairs at IQVIA.
By releasing these principles and associated actions, the CROs and technology providers of ACRO hope to spur further collaboration across all stakeholders and make collective progress toward a clinical research ecosystem that better serves all patient communities and is more representative of the world we live in
Read more about the Principles and ACRO’s diversity and inclusion efforts: https://www.acrohealth.org/diversity-equity-and-inclusion-in-clinical-trials/
The Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized tools and services to support the development of new pharmaceuticals, biologics, and medical devices. Through its member companies, ACRO works to improve the quality, efficiency, and safety of biomedical research. ACRO member companies operate in more than 100 countries across the globe and conduct or support the conduct of a majority of clinical trials across all therapeutic areas. For further comments or press inquiries, please contact Sophia McLeod at [email protected].